Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Recruiting
Observational Study
Atrial Fibrillation (AF)
Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient over 18 years of age
* History of AD
* Currently on DOACs.
* Capacity to understand the study procedures and provide informed consent.
Exclusion Criteria:
* Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
* Unable to complete a follow-up pe…
Contacts
No contact information available.